ORTHOVISC 2 ml

ORTHOVISC

Medical device

Intra-articular hyaluronic acid viscosupplement

Classified and marketed as an intra Articular hyaluronic acid viscosupplement medical device for osteoarthritis pain relief in accordance with applicable regulatory frameworks.
High Purity, non Animal Sourced sodium hyaluronate manufactured under Good Manufacturing Practice (GMP) for medical devices.
In many markets ORTHOVISC carries a CE mark as a viscoelastic supplement or replacement for synovial fluid in human joints.

Classified and marketed as an intra Articular hyaluronic acid viscosupplement medical device for osteoarthritis pain relief in accordance with applicable regulatory frameworks.
High Purity, non Animal Sourced sodium hyaluronate manufactured under Good Manufacturing Practice (GMP) for medical devices.
In many markets ORTHOVISC carries a CE mark as a viscoelastic supplement or replacement for synovial fluid in human joints.
Subject to national regulatory approvals (for example, FDA premarket approval as an intra Articular HA device for knee OA in the United States).

Description

ORTHOVISC 2 ml is a high molecular weight, ultra-pure hyaluronic acid (sodium hyaluronate) injection used as a viscosupplement to relieve joint pain caused by osteoarthritis, particularly in the knee. It is supplied as a sterile, prefilled 2 ml syringe containing a concentrated solution of non-animal-sourced sodium hyaluronate (15 mg/ml) in physiological saline. Injected directly into the affected joint, ORTHOVISC supplements the degraded synovial fluid, improving lubrication and shock absorption, and helping to reduce pain and improve joint function in patients who have not responded adequately to simple analgesics and conservative non-pharmacologic therapies.

Bnefits

Provides clinically proven relief of knee pain due to osteoarthritis when conservative treatments and simple analgesics are insufficient.
High molecular weight, highly purified sodium hyaluronate (15 mg/ml) formulated for optimal viscoelastic and lubricating properties in the joint.
Non-animal-sourced hyaluronic acid in physiological saline, offering excellent biocompatibility and resorbability.
Multi-injection treatment course (typically 3–4 intra-articular injections) can provide pain relief and functional improvement for up to 6 months.
Improves joint lubrication and shock absorption, helping to reduce friction and mechanical stress on articular cartilage.
Can delay or reduce the need for more invasive interventions such as joint replacement in some patients.
Favourable safety and tolerability profile when administered by appropriately trained clinicians.
Single-use, prefilled 2 ml syringe presentation simplifies preparation, reduces contamination risk and supports accurate dosing.

Indications

Treatment of pain in osteoarthritis of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy (e.g. physiotherapy, weight reduction) and to simple analgesics (e.g. paracetamol/acetaminophen).
In many markets outside the US, indicated as a viscoelastic supplement or replacement for synovial fluid in human synovial joints affected by osteoarthritis, where its actions are lubrication and mechanical support.